人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學(xué)習(xí)資料_第1頁(yè)
人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學(xué)習(xí)資料_第2頁(yè)
人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學(xué)習(xí)資料_第3頁(yè)
人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學(xué)習(xí)資料_第4頁(yè)
人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學(xué)習(xí)資料_第5頁(yè)
已閱讀5頁(yè),還剩42頁(yè)未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

AntiepilepticandAnticonvulsiveDrugsLouhaiyanInstituteofPharmacologySchoolofMedicineShandongUniversitylouhaiyan@1Section1AntiepilepticDrugs

2Epilepsy(癲癇)3Aseizureistheclinicalmanifestationofasudden,excessiveandsynchronousdischargeoffocalneuronsanddiffusiontonormalneuronaltissues.Epilepsyischaracterizedby

recurrent,suddenandtransientseizures.Definitionofepilepsy

sensorydisorder,behaviordisorder,andpsychotic4Classificationsofseizuretypes1.Partialseizures(局限性發(fā)作)①Simplepartialseizures(單純性局限性發(fā)作)②Complexpartialseizures(復(fù)合性局限性發(fā)作)Psychomotorseizures(精神運(yùn)動(dòng)性發(fā)作)2.Generalizedseizures(全身性發(fā)作)①Absence(petitmal)seizures(失神性發(fā)作,小發(fā)作)②Myoclonicseizures(肌陣攣性發(fā)作)③Generalizedtonic-clonic(gradmal)seizures(強(qiáng)直-陣攣性發(fā)作,大發(fā)作)④Statusepilepticus

(癲癇持續(xù)狀態(tài))5CauseofepilepsyIdiopathicepilepsyComplicatedGeneticSecondaryepilepsyCNSinfectionTraumaTumorParasitesetc6PathogenesisofepilepsyinitiationandspreadImbalancefunctionofneurotransmittersandinstableneuronalmembrane

7EEGRecordsDuringEpilepticSeizureEpilepsyischaracterizedbyuncontrolledexcessiveactivityofeitherapartorallofthecentralnervoussystem.Grandmalepilepsy:characterizedbyextremeneuronaldischargesinallareasofthebrain,lastfromafewsecondsto3to4minutes.Petitmalepilepsy:Characterizedby3to30secondsofunconsciousnessordiminishedconsciousnessduringwhichthepersonhasseveraltwitch-likecontractionsofthemuscle.8DiagnosisofEpilepsyYesorNo?HistoryClassificationReason?9TreatmentofEpilepsyAim:Keepthepatientfreeofseizures,withnoadverseeffects,notaffectingthelifequality.CauseDrugtreatmentSurgeryorphysicaltherapy101.Blocktheinitiationofabnormalofabnormaldischargefromthefocalarea.2.Preventthespreadofabnormaldischargetoadjacentbrainareas.Mechanismsofantiepilepsydrugs

ActionPatterns:11Mechanismsofantiepilepticdrugs

1.Decreaseactivityofvoltage-dependentNa+channels2.Decreaseactivityofvoltage-dependentCa2+channelsN-type(neuronal);L-type(longlasting)T-type(transient)3.EnhanceGABAergictransmissiondecreasethereuptakeormetabolismofGABAdirectactionontheGABAA-R4.

Diminishglutamatefunction

12

Section2

Commonly-usedantiepilepticdrugs13

phenytoinsodium(苯妥英鈉)

barbiturates:phenbarbital(苯巴比妥)

primidone(撲米酮)

carbamazepine(卡馬西平)

ethosuximide(乙琥胺)

sodiumvalproate(丙戊酸鈉)

benzodiazepines:

diazepam(地西泮)

nitrozepam(硝西泮)

clonazepam(氯硝西泮)

antiepilepsirine(抗癇靈)

newerdrugs:flunarizine(氟桂利嗪)

lamotrigine(拉莫三嗪)

topiramate(托吡酯)14

1.PhenytoinSodium

(苯妥英鈉,Dilantin,大侖丁)15

【Pharmacologicalactions】CannotinhibitthedischargeofneuroninfocusPreventthediffusioninnormalneuroninhibitposttetanic

potentiation(PTP,強(qiáng)直后增強(qiáng)):反復(fù)高頻電刺激(強(qiáng)直刺激)突觸前神經(jīng)纖維,引起突觸傳遞易化,使突觸后纖維反應(yīng)增強(qiáng)的現(xiàn)象16Membrane-stabilizingfunction1.

blockvoltage-sensitiveNa+channel2.

blockvoltage-sensitiveCa2+channel(Ltype,Ntype)

3.inhibittheactivityofcalmodulin

kinase

(鈣調(diào)素激酶)presynapticmembrane—Glurelease↓postsynapticmembrane—depolarization↓【Mechanismsofaction】171.Epilepsy:

generalizedtonic-clonicseizures(gradmal)

andpartialseizures

(firstchoice)

except

absenceseizures(petitmal)

(noeffect,evenexacerbatedisease)

【clinicaluses】attention:slowonsetphenobabital→phenytoinsodium183.

Ventriculararrhythmia(心律失常):

cardiacglycosideinduced(強(qiáng)心苷中毒)-firstchoice2.Neuralgias:

trigeminalneuralgia(三叉神經(jīng)痛)glossopharyngealneuralgia(舌咽神經(jīng)痛)【clinicaluses】191.Absorptionstrongirritation(alkaline,pH=10.4),notim.Oral:unpredictable,slowonset

Css:6-10d(10-20ug/ml)iv.forstatusepilepticus

【Pharmacokinetics】20【Pharmacokinetics】2.Metabolism:mainlyinliver,hepaticenzymeinduction

≤10g/ml:first-ordereliminationkinetics,

t1/2=20h

≥10g/ml:zero-ordereliminationkinetics,t1/2=60hmonitorblooddrugconcentration(10-20g/ml)3.C=10g/ml(anti-epilepsy)

C=20g/ml(intoxication)211.Localstimulation①gastrointestinalirritation②phlebitis(靜脈炎)③gingivalhyperplasia20%AdverseReactions222.CNSsymptoms

20g/ml:dizziness,ataxia﹥40g/ml:psychoticdisiorder﹥50g/ml:coma

233.Megaloblasticanemia防治:甲酰四氫葉酸4.Hypocalcemia,

osteomalacia(軟骨癥)

rachitis(佝僂病):children防治:VitD24AdverseReactions5.Allergyskinrash

agranulocytosis(粒細(xì)胞缺乏)

thrombocytopenia(血小板減少)

aplasticanemia(再生障礙性貧血)

hepaticlesion

256.Teratogenesis

【AdverseReactions】fetalhydantoinsyndrome(胎兒妥因綜合征)26

芬蘭1980~1998年,研究人員追蹤了一家產(chǎn)科診所中970位懷孕的癲癇婦女,其中有740位在懷孕初期(前3個(gè)月)服用抗癲癇藥物,另外239位則無(wú)。結(jié)果在這些服用抗癲癇藥物的懷孕婦女中,共產(chǎn)下28個(gè)嚴(yán)重畸形兒(3.8%),未服用抗癲癇藥物組產(chǎn)下2個(gè)嚴(yán)重畸形兒(0.8%;P=0.02)27

2.Phenobarbital(苯巴比妥)【Pharmacologicalactionsandclinicaluses】1.rapidonset2.usedforgeneralizedtonic-clonicseizuresand

statusepilepticus(iv),butnotfirstchoice

Mechanisms:inhibitinitiationandspreadofabnormaldischarge

increaseGABAinducedCl-in(extendopeningtime)inhibitexcitatoryneurotransmitter-mediatedeffecthighdoseinhibitNa+,Ca2+(LandN-type)channel28

3.Primidone(撲米酮)activemetabolites:

phenobarbital

phenylethylmalonamides(PEMA,苯乙基丙二酰胺)294.Ethosuximide(乙琥胺)Theonlyindication:

absenceepilepsy-firstchoiceMechanisms:inhibittheT-typeCa2+currentin

thalamicneurons

301.Diazepam:statusepilepticus-firstchoice

(iv,slow)2.Nitrazepam(硝西泮):absenceseizure,myoclonicseizure,infantilespasm3.Clonazepam(氯硝西泮):broad-spectrum5.Benzodiazepines316.SodiumValproate

(丙戊酸鈉)Uses:Broad-spectrumLesseffectiveforgradmalthanphenytoinand

phenobarbital

Similareffectiveforpartialmalwithcarbamazepine

Moreeffectivethanethosuximideforabsenceseizurebutnotthefirstchoiceduetohepatictoxicity.Gradmalcombinedwithabsenceseizure-firstchoice

Refractoryepilepsy(頑固性癲癇)32

Mechanisms:inhibitdischargespreadenhanceGABAfunction:

inhibitNa+,T-typeCa2+channel33SodiumValproateGADGABA-TglutamicacidsuccinicacidsemialdehydeGABA+-6.SodiumValproate

(丙戊酸鈉)GAD:谷氨酸脫羧酶GABA-T:谷氨酸轉(zhuǎn)氨酶琥珀酸半醛34AdverseReactionsGastrointestinalreactionsandCNSreactionsLiverinjury:25%routineexaminationTeratogenesis357.Carbamazepine(卡馬西平)【Pharmacologicalactionsandclinicaluses】1.Epilepsy:broadspectrum

gradmal,complexpartialseizures-firstchoice

nogoodforabsenceepilepsy2.Neuralgias:moreeffectivethanphenytoinMechanismsinhibitNa+、Ca2+channelenhanceGABAinhibitoryfunction3.Diabetesinsipidus

(尿崩癥)

4.Maniaanddepression(躁狂抑郁癥)36尿崩癥AVP(argininevasopressin):精氨酸加壓素ADH(antidiuretichormone):抗利尿激素卡馬西平:促進(jìn)ADH分泌病因:下丘腦-神經(jīng)垂體部位的病變↓ADH(AVP),

腎小管重吸收功能障礙多尿、煩渴、多飲與低比重尿37OthersAntiepilepsirin(抗癇靈)flunarizine(氟桂利嗪)Lamotrigine(拉莫三嗪)Topiramate(托吡酯,妥泰)newer38Principles1.Selectdrugaccordingtoepilepsyclassification2.Increasedosegradually3.Transitionaldrugchange:addaseconddrugbeforestopthefirstone4.Withdrawslowly(halfyear)5.Monitorhemogram(血象)andliverfunction6.Pregnantwomanshouldtakecaution39對(duì)癥選藥原則癲癇類(lèi)型首選藥物大發(fā)作和局限性發(fā)作苯妥英鈉小發(fā)作乙琥胺大發(fā)作和精神運(yùn)動(dòng)型性發(fā)作卡馬西平癲癇持續(xù)狀態(tài)地西泮iv大發(fā)作合并小發(fā)作丙戊酸鈉40++++++++++41Principles1.對(duì)癥選藥2.劑量漸增3.先加后撤4.久用慢停5.肝功血象6.孕婦慎用42Section3Anticonvulsants

BarbituratesBenzodiazepinesChloralhydrateMagnesiumSulfate43MagnesiumSulfatedifferentadministrationroutes→differenteffects1.oral—catharsis,cholagogue(導(dǎo)瀉、利膽)2.external—dephlogisticate(消炎)3.ivorim—

anticonvulsive:relaxantofskeletalmuscle

BPlowering:inhibitcardiacmuscle,dilateVSM

Mechanism:calciumantagonismUses:

hypertensivecrisis,convulsion44MagnesiumSulfatetendonreflex(腱反射)Overdose:respiratoryinhibitionandhypotensionTreatment:artificialbreathingivcalciumchlorideorcalciumgluconate4546CasehistoryGabyisa22

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論